Filings For: Marker Therapeutics, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Marker Therapeutics, Inc. (MRKR) 8/14/2026 4:55:35 PM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $14,585,485 EPS -$0.09
Marker Therapeutics, Inc. (MRKR) 5/15/2026 5:15:52 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $17,434,008 EPS -$0.16
Marker Therapeutics, Inc. (MRKR) 3/20/2026 4:10:06 PM   View Proxy SEC Y 2025
Marker Therapeutics, Inc. (MRKR) 3/19/2026 6:01:30 AM   View Financials Earnings SEC Y 2025 Rev $1,103,444 -51.0% Assets $19,070,997 EPS -$0.04 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 3/18/2026 5:40:00 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Rev: $3,546,669 -46.2% Assets $19,070,997 EPS -$0.79
Marker Therapeutics, Inc. (MRKR) 3/18/2026 5:33:08 PM   View Financials Earnings WIRE Y 2025 Rev $1,103,444 -51.0% Assets $19,070,997 EPS -$0.04 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/14/2025 7:21:16 AM   View Financials Earnings SEC 3Q 2025 Rev $1,232,938 -36.0% Assets $21,734,830 EPS -$0.12 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/13/2025 5:46:51 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Rev: $1,232,938 -36.0% Assets $21,734,830 EPS -$0.12
Marker Therapeutics, Inc. (MRKR) 8/14/2025 5:23:54 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Rev: $861,184 -26.3% Assets $14,767,870 EPS -$0.29
Marker Therapeutics, Inc. (MRKR) 5/15/2025 5:15:19 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Rev: $349,104 -71.9% Assets $16,993,266 EPS -$0.40
Marker Therapeutics, Inc. (MRKR) 4/24/2025 5:01:24 PM   View Proxy SEC Y 2024
Marker Therapeutics, Inc. (MRKR) 3/31/2025 8:49:32 AM   View Financials Earnings SEC Y 2024 Rev $2,251,763 +113.1% Assets $22,022,860 EPS -$0.42 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 3/31/2025 8:24:10 AM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Rev: $6,591,080 +99.1% Assets $22,022,860 EPS -$1.19
Marker Therapeutics, Inc. (MRKR) 2/4/2025 4:06:34 PM   View Proxy SEC Y 2024
Marker Therapeutics, Inc. (MRKR) 11/14/2024 4:47:42 PM   View Financials Earnings SEC 3Q 2024 Rev $1,926,020 +647.7% Assets $10,910,348 EPS -$0.26 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/14/2024 4:25:03 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Rev: $1,926,020 +647.7% Assets $10,910,348 EPS -$0.26
Marker Therapeutics, Inc. (MRKR) 8/14/2024 4:48:56 PM   View Financials Earnings SEC 2Q 2024 Rev $1,169,236 +53.3% Assets $11,675,005 EPS -$0.25 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 8/14/2024 4:46:14 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Rev: $1,169,236 +53.3% Assets $11,675,005 EPS -$0.25
Marker Therapeutics, Inc. (MRKR) 5/15/2024 4:45:33 PM   View Financials Earnings SEC 1Q 2024 Rev $1,244,061 +0.8% Assets $14,091,899 EPS -$0.27 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 5/15/2024 4:17:46 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Rev: $1,244,061 +0.8% Assets $14,091,899 EPS -$0.27
Marker Therapeutics, Inc. (MRKR) 4/26/2024 4:09:09 PM   View Proxy SEC Y 2023
Marker Therapeutics, Inc. (MRKR) 3/26/2024 6:17:08 AM Micro View Financials 10-K SEC Y 2023 ending: 12/31/2023 Rev: $3,311,133 -5.8% Assets $17,127,391 EPS -$0.94
Marker Therapeutics, Inc. (MRKR) 3/26/2024 6:02:49 AM   View Financials Earnings SEC Y 2023 Rev $1,056,532 +39.2% Assets $17,127,391 EPS -$0.32 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/9/2023 5:05:49 PM   View Financials Earnings SEC 3Q 2023 Rev $257,606 -74.2% Assets $19,486,567 EPS -$0.34 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/9/2023 4:47:21 PM Micro View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Rev: $257,606 -74.2% Assets $19,486,567 EPS -$0.34
Marker Therapeutics, Inc. (MRKR) 8/14/2023 4:44:46 PM   View Financials Earnings SEC 2Q 2023 Rev $762,658 -3.5% Assets $21,955,648 EPS $0.29 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 8/14/2023 4:16:28 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Rev: $762,658 -3.5% Assets $21,955,648 EPS $0.29
Marker Therapeutics, Inc. (MRKR) 5/15/2023 4:24:14 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Rev: $1,234,336 +28.0% Assets $27,941,047 EPS -$0.57
Marker Therapeutics, Inc. (MRKR) 4/28/2023 4:13:56 PM   View Proxy SEC Y 2022
Marker Therapeutics, Inc. (MRKR) 3/22/2023 8:19:51 AM   View Financials Earnings SEC Y 2022 Rev $759,143 -38.9% Assets $34,422,184 EPS -$0.45 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 3/22/2023 8:11:49 AM Micro View Financials 10-K SEC Y 2022 ending: 12/31/2022 Rev: $3,513,544 +183.0% Assets $34,422,184 EPS -$3.58
Marker Therapeutics, Inc. (MRKR) 11/10/2022 4:29:55 PM   View Financials Earnings SEC 3Q 2022 Rev $999,571 Assets $41,114,565 EPS -$0.83 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/10/2022 4:16:58 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Rev: $999,571 Assets $41,114,565 EPS -$0.83
Marker Therapeutics, Inc. (MRKR) 8/11/2022 4:46:25 PM Micro View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Rev: $790,508 Assets $52,319,738 EPS -$1.11
Marker Therapeutics, Inc. (MRKR) 8/11/2022 4:42:50 PM   View Financials Earnings SEC 2Q 2022 Rev $790,508 Assets $52,319,738 EPS -$1.11 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 5/13/2022 7:12:41 AM   View Financials Earnings SEC 1Q 2022 Rev $964,322 Assets $54,956,134 EPS -$1.19 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 5/13/2022 6:21:23 AM Micro View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Rev: $964,322 Assets $54,956,134 EPS -$1.19
Marker Therapeutics, Inc. (MRKR) 4/15/2022 4:32:33 PM   View Proxy SEC Y 2021
Marker Therapeutics, Inc. (MRKR) 3/18/2022 6:03:21 AM   View Financials Earnings SEC Y 2021 Rev $1,241,710 Assets $68,135,134 EPS -$5.04 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 3/17/2022 5:32:01 PM Micro View Financials 10-K SEC Y 2021 ending: 12/31/2021 Rev: $1,241,710 +166.0% Assets $68,135,134 EPS -$5.47
Marker Therapeutics, Inc. (MRKR) 11/10/2021 5:28:30 PM   View Financials Earnings SEC 3Q 2021 Assets $71,939,775 EPS -$0.15 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/10/2021 4:21:32 PM Micro View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Assets $71,939,775 EPS -$0.15
Marker Therapeutics, Inc. (MRKR) 8/10/2021 4:12:37 PM Micro View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Assets $80,470,983 EPS -$0.13
Marker Therapeutics, Inc. (MRKR) 8/10/2021 4:10:56 PM   View Financials Earnings SEC 2Q 2021 Assets $80,470,983 EPS -$0.13 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 5/12/2021 4:23:52 PM Micro View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Assets $88,362,081 EPS -$0.16
Marker Therapeutics, Inc. (MRKR) 5/12/2021 4:19:13 PM   View Financials Earnings SEC 1Q 2021 Assets $88,362,081 EPS -$0.16 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 5/5/2021 4:49:43 PM   View Proxy SEC Y 2020
Marker Therapeutics, Inc. (MRKR) 4/23/2021 4:32:35 PM   View Proxy SEC Y 2020
Marker Therapeutics, Inc. (MRKR) 3/9/2021 4:53:54 PM Micro View Financials 10-K SEC Y 2020 ending: 12/31/2020 Rev: $466,785 +118.9% Assets $45,614,815 EPS -$0.61
Marker Therapeutics, Inc. (MRKR) 3/9/2021 4:37:43 PM   View Financials Earnings SEC Y 2020 Rev $0 Assets $45,614,815 EPS -$0.18 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/9/2020 4:23:19 PM   View Financials Earnings SEC 3Q 2020 Rev $0 Assets $48,571,188 EPS -$0.16 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/9/2020 4:16:36 PM Micro View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Assets $48,571,188 EPS -$0.16
Marker Therapeutics, Inc. (MRKR) 8/10/2020 4:32:57 PM   View Financials Earnings SEC 2Q 2020 Rev $466,785 Assets $48,523,604 EPS -$0.14 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 8/10/2020 4:20:06 PM Micro View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Rev: $466,785 Assets $48,523,604 EPS -$0.14
Marker Therapeutics, Inc. (MRKR) 5/11/2020 4:22:47 PM   View Financials Earnings SEC 1Q 2020 Assets $42,885,656 EPS -$0.14 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 5/11/2020 4:15:40 PM Micro View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020 Assets $42,885,656 EPS -$0.14
Marker Therapeutics, Inc. (MRKR) 4/17/2020 4:02:22 PM   View Proxy SEC Y 2019
Marker Therapeutics, Inc. (MRKR) 3/12/2020 4:38:37 PM   View Financials Earnings SEC Y 2019 Rev $213,194 Assets $46,359,282 EPS -$0.11 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 3/12/2020 4:15:52 PM Micro View Financials 10-K SEC Y 2019 ending: 12/31/2019 Rev: $213,194 +3.5% Assets $46,359,282 EPS -$0.47
Marker Therapeutics, Inc. (MRKR) 11/12/2019 4:25:24 PM   View Financials Earnings SEC 3Q 2019 Rev $0 Assets $51,402,472 EPS -$0.12 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 11/12/2019 4:24:10 PM Micro View Financials 10-Q SEC 3Q 2019 ending: 9/30/2019 Assets $51,402,472 EPS -$0.12
Marker Therapeutics, Inc. (MRKR) 8/9/2019 8:48:47 AM Micro View Financials 10-Q SEC 2Q 2019 ending: 6/30/2019 Assets $54,995,221 EPS -$0.12
Marker Therapeutics, Inc. (MRKR) 8/9/2019 6:14:04 AM   View Financials Earnings SEC 2Q 2019 Rev $0 Assets $54,995,221 EPS -$0.12 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 5/10/2019 5:19:25 PM Micro View Financials 10-Q SEC 1Q 2019 ending: 3/31/2019 Assets $58,987,914 EPS -$0.12
Marker Therapeutics, Inc. (MRKR) 5/9/2019 5:10:35 PM   View Financials Earnings SEC 1Q 2019 Assets $58,987,914 EPS -$0.12 Export Earnings Model
Marker Therapeutics, Inc. (MRKR) 3/28/2019 5:16:33 PM   View Proxy SEC Y 2018
Marker Therapeutics, Inc. (MRKR) 3/15/2019 5:11:59 PM Micro View Financials 10-K SEC Y 2018 ending: 12/31/2018 Rev: $205,994 +12.5% Assets $62,144,310 EPS -$7.75
Marker Therapeutics, Inc. (MRKR) 11/13/2018 4:22:33 PM Micro View Financials 10-Q SEC 3Q 2018 ending: 9/30/2018 Assets $4,391,238 EPS -$0.32
TAPIMMUNE INC. (MRKR) 9/14/2018 2:55:53 PM   View Proxy SEC Y 2017
TAPIMMUNE INC. (MRKR) 8/9/2018 5:11:47 PM Micro View Financials 10-Q SEC 2Q 2018 ending: 6/30/2018 Rev: $205,994 Assets $7,891,678 EPS -$0.41
TAPIMMUNE INC. (MRKR) 5/15/2018 4:35:05 PM Micro View Financials 10-Q SEC 1Q 2018 ending: 3/31/2018 Assets $2,930,120 EPS -$0.30
TAPIMMUNE INC. (MRKR) 3/23/2018 5:27:14 PM Micro View Financials 10-K SEC Y 2017 ending: 12/31/2017 Rev: $183,064 Assets $5,180,439 EPS -$1.16
TAPIMMUNE INC. (MRKR) 11/14/2017 4:25:17 PM Micro View Financials 10-Q SEC 3Q 2017 ending: 9/30/2017 Rev: $183,064 Assets $7,704,265 EPS -$0.39
TAPIMMUNE INC. (MRKR) 8/7/2017 5:44:23 PM Micro View Financials 10-Q SEC 2Q 2017 ending: 6/30/2017 Assets $10,141,796 EPS -$0.22
TAPIMMUNE INC. (MRKR) 7/12/2017 1:44:48 PM   View Proxy SEC Y 2016
TAPIMMUNE INC (MRKR) 5/5/2017 4:13:34 PM Micro View Financials 10-Q SEC 1Q 2017 ending: 3/31/2017 Assets $6,105,076 EPS -$0.29
TAPIMMUNE INC (MRKR) 3/14/2017 4:04:06 PM Micro View Financials 10-K SEC Y 2016 ending: 12/31/2016 Assets $7,921,392 EPS -$0.72
TAPIMMUNE INC (MRKR) 11/4/2016 4:02:33 PM Micro View Financials 10-Q SEC 3Q 2016 ending: 9/30/2016 Assets $9,698,425 EPS -$0.29
TAPIMMUNE INC (MRKR) 8/15/2016 5:18:53 PM Micro View Financials 10-Q SEC 2Q 2016 ending: 6/30/2016 Rev: $231,200 Assets $3,789,050 EPS $0.35
TAPIMMUNE INC (MRKR) 5/16/2016 4:42:26 PM Micro View Financials 10-Q SEC 1Q 2016 ending: 3/31/2016 Assets $5,759,433 EPS -$0.81
TAPIMMUNE INC (MRKR) 4/14/2016 4:48:02 PM Micro View Financials 10-K SEC Y 2015 ending: 12/31/2015 Assets $6,645,367 EPS -$9.30
TAPIMMUNE INC (MRKR) 4/14/2016 4:39:33 PM Micro View Financials 10-Q/A SEC 3Q 2015 ending: 9/30/2015 Assets $6,225,302 EPS $4.23
TAPIMMUNE INC (MRKR) 4/14/2016 4:32:03 PM Micro View Financials 10-Q/A SEC 2Q 2015 ending: 6/30/2015 Assets $3,247,910 EPS -$1.80
TAPIMMUNE INC (MRKR) 4/14/2016 4:26:01 PM Micro View Financials 10-Q/A SEC 1Q 2015 ending: 3/31/2015 Assets $1,536,009 EPS -$0.03
TAPIMMUNE INC (MRKR) 11/16/2015 4:45:25 PM Micro View Financials 10-Q SEC 3Q 2015 ending: 9/30/2015 Assets $6,225,302 EPS $4.23
TAPIMMUNE INC (MRKR) 8/14/2015 4:27:39 PM Micro View Financials 10-Q SEC 2Q 2015 ending: 6/30/2015 Assets $3,247,910 EPS -$1.80
TAPIMMUNE INC (MRKR) 5/15/2015 4:57:12 PM Micro View Financials 10-Q SEC 1Q 2015 ending: 3/31/2015 Assets $1,536,009 EPS -$0.03
TAPIMMUNE INC (MRKR) 4/15/2015 4:02:33 PM Micro View Financials 10-K SEC Y 2014 ending: 12/31/2014 Assets $224,448 EPS -$2.00
TAPIMMUNE INC (MRKR) 11/19/2014 4:56:10 PM Micro View Financials 10-Q SEC 3Q 2014 ending: 9/30/2014 Assets $643,649 EPS -$0.09
TAPIMMUNE INC (MRKR) 8/18/2014 3:40:34 PM Micro View Financials 10-Q SEC 2Q 2014 ending: 6/30/2014 Assets $35,651 EPS $0.05
TAPIMMUNE INC (MRKR) 5/21/2014 4:33:09 PM Micro View Financials 10-Q/A SEC 1Q 2014 ending: 3/31/2014 Assets $109,386 EPS -$3.89
TAPIMMUNE INC (MRKR) 4/17/2014 5:30:00 AM Micro View Financials 10-K/A SEC Y 2013 ending: 12/31/2013 Assets $77,032 EPS -$4.87
TAPIMMUNE INC (MRKR) 1/28/2014 1:32:15 PM   View Proxy SEC Y 2013
TAPIMMUNE INC (MRKR) 11/19/2013 5:08:58 PM Micro View Financials 10-Q SEC 3Q 2013 ending: 9/30/2013 Assets $150,021
TAPIMMUNE INC (MRKR) 8/19/2013 4:43:01 PM Micro View Financials 10-Q SEC 2Q 2013 ending: 6/30/2013 Assets $185,306 EPS -$0.87
TAPIMMUNE INC (MRKR) 8/19/2013 4:41:25 PM Micro View Financials 10-Q/A SEC 1Q 2013 ending: 3/31/2013 EPS -$0.55
TAPIMMUNE INC (MRKR) 5/21/2013 5:30:00 AM Micro View Financials 10-Q SEC 1Q 2013 ending: 3/31/2013 EPS -$0.55
TAPIMMUNE INC (MRKR) 5/15/2013 5:28:35 PM Micro View Financials 10-K SEC Y 2012 ending: 12/31/2012 Assets $87,372 EPS -$9.42
TAPIMMUNE INC (MRKR) 11/19/2012 3:43:26 PM Micro View Financials 10-Q SEC 3Q 2012 ending: 9/30/2012 Assets $60,739 EPS -$0.01
TAPIMMUNE INC (MRKR) 9/12/2012 4:56:34 PM Micro View Financials 10-Q/A SEC 2Q 2012 ending: 6/30/2012 Assets $64,180 EPS -$0.04
TAPIMMUNE INC (MRKR) 5/21/2012 2:11:41 PM Micro View Financials 10-Q SEC 1Q 2012 ending: 3/31/2012 Assets $94,774 EPS -$0.01
TAPIMMUNE INC (MRKR) 4/16/2012 4:27:32 PM Micro View Financials 10-K SEC Y 2011 ending: 12/31/2011 Assets $307,921 EPS -$0.04
TAPIMMUNE INC (MRKR) 11/21/2011 3:52:06 PM Micro View Financials 10-Q SEC 3Q 2011 ending: 9/30/2011 Assets $97,067
TAPIMMUNE INC (MRKR) 8/22/2011 2:54:50 PM Micro View Financials 10-Q SEC 2Q 2011 ending: 6/30/2011 Assets $92,037 EPS -$0.01
TAPIMMUNE INC (MRKR) 1/29/2010 3:28:14 PM   View Proxy SEC Y 2009